Swiss biotech industry growing rapidly

The European biotech industry is on a growth course according to a report by McKinsey. The availability of capital and skilled workers is rising. Switzerland is one of the top three European countries for the speed of growth of the biotech industry.

Switzerland is among the three countries in Europe where the biotech industry is growing fastest. Generic image: jarmoluk/Pixabay

The biotech industry in Europe is on a growth course, the consultancy firm McKinsey writes in a new report. Growth is above all being driven by innovations in the areas of cell therapy, gene therapy, mRNA, and immunotherapies with CAR T-cells.

Improved access to capital

The availability of capital – from both private and public sources – is increasing at a record speed worldwide. European biotech companies are also attracting more and more money. They are catching up with their counterparts in the USA and China in particular with the average late-stage funding. With respect to the availability of skilled workers, the USA is still dominant. However, Europe is catching up in this regard.

Europe is world class for science

Europe is already world class for science. Overall, Europe has a clear lead on China, the USA and the rest of the world when it comes to the quality and quantity of its scientific research. McKinsey highlights that 43 of the world’s 100 leading bioscience universities are located in Europe. This figure is 34 for the USA.

Swiss biotech hub growing strongly

With regard to innovation, large differences can be seen between the individual countries in Europe. The UK, France, and Germany are the three largest biotech centers in Europe and together they make up half of all European biotechs. Meanwhile, the UK, France and Switzerland report the fastest growth and are home to 63 percent of biotech companies established between 2018 and 2020. In other European countries such as Germany, the pace of innovation has remained the same, and in some cases it has even lost momentum.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Read more
How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program